Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Open Access
- 1 February 2011
- journal article
- research article
- Published by Taylor & Francis Ltd in Vascular Health and Risk Management
- Vol. 7, 49-57
- https://doi.org/10.2147/VHRM.S16925
Abstract
Peer reviewed article authored by (Anja Schweizer, Sylvie Dejager, James E Foley, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 37 references indexed in Scilit:
- Effect of vildagliptin as add-on therapy to a low-dose metforminWorld Journal of Diabetes, 2010
- Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitusDiabetes, Obesity and Metabolism, 2009
- Efficacy and Tolerability of Vildagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin MonotherapyHormone and Metabolic Research, 2009
- Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naïve Patients with Type 2 Diabetes: Comparison with MetforminHormone and Metabolic Research, 2008
- Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia*Diabetes, Obesity and Metabolism, 2008
- Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24‐week, double‐blind, randomized trialDiabetic Medicine, 2008
- Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24‐week, randomized, double‐blind study*Diabetes, Obesity and Metabolism, 2007
- Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetesDiabetes Research and Clinical Practice, 2007
- Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo‐controlled study*Diabetes, Obesity and Metabolism, 2006
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004